Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin in Acute Ischemic Stroke
NCT00868283Phase 4Completed
- Sponsor
- EVER Pharma
- Start
- Sep 2006
- Primary completion
- Oct 2010
- Modality
- Native Peptides
- Countries
- 3
01
Overview
A Phase 4 trial of cerebrolysin in ischemic stroke, sponsored by EVER Pharma. Started Sep 2006; status: completed.
02
Drugs
cerebrolysin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00868283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00868283.